Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.1313
-0.0076 (-5.47%)
Mar 31, 2025, 1:22 PM EDT - Market open

Lyra Therapeutics Stock Forecast

LYRA's stock price has decreased by -97.83% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Lyra Therapeutics stock have an average target of 1.25, with a low estimate of 0.50 and a high estimate of 2.00. The average target predicts an increase of 852.02% from the current stock price of 0.13.

Analyst Consensus: Hold
Target Low Average Median High
Price $0.50 $1.25 $2.00 $2.00
Change +280.81% +852.02% +1423.2% +1423.2%

Analyst Ratings

The average analyst rating for Lyra Therapeutics stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 111110
Buy 111111
Hold 333333
Sell 000000
Strong Sell 000000
Total 555554

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
$2
Hold Reiterates $2 +1,423.23% Mar 14, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
n/a
Buy Reiterates n/a n/a Aug 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
$2
Hold Reiterates $2 +1,423.23% Aug 15, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
n/a
Buy Reiterates n/a n/a Jun 20, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
$2
Hold Downgrades $2 +1,423.23% May 7, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
996.80K
from 1.53M
Decreased by -35.02%
Revenue Next Year
6.18M
from 996.80K
Increased by 519.89%
EPS This Year
-0.73
from -1.43
EPS Next Year
-0.86
from -0.73
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
-285.00K1.36M1.56M1.53M996.80K6.18M18.08M
Revenue Growth
--378.25%14.31%-1.54%-35.02%519.89%192.62%
EPS
-2.59-3.35-1.83-1.26-1.43-0.73-0.86-0.69
EPS Growth
--------
Forward PE
--------
No. Analysts -----643
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 1.7M 11.9M 37.2M
Avg 996,795 6.2M 18.1M
Low n/a 803,600 n/a

Revenue Growth

Revenue Growth 20252026202720282029
High
8.7%
1,089.8%
502.4%
Avg
-35.0%
519.9%
192.6%
Low -
-19.4%
-

EPS Forecast

EPS 202520262027
High -0.38 -0.86 -0.71
Avg -0.73 -0.86 -0.69
Low -1.01 -0.84 -0.67

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.